What our tracking knows about this posting
Published on 13 August 2026 · first appeared in our records on 20 September 2026.
Stable posting: first seen on 20 September 2026, with no abnormal reposting.
This posting shows no salary, while 24% of open postings in the same sector in this country (Austria) do.
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revo…